Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Foundation Medicine Company Profile (NYSE:FMI)

Consensus Ratings for Foundation Medicine (NYSE:FMI) (?)
Ratings Breakdown: 7 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.30)
Consensus Price Target: $44.50 (27.65% upside)

Current Analysts' Coverage Summary for Foundation Medicine (NYSE:FMI)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015WedbushReiterated RatingNeutral$45.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015JMP SecuritiesReiterated RatingOutperform$67.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Goldman SachsReiterated RatingNeutral$55.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Leerink SwannReiterated RatingMarket Perform$50.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015JPMorgan Chase & Co.Reiterated RatingHold$31.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/17/2014William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/1/2014Tigress FinancialInitiated CoverageNeutral -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Janney Montgomery ScottInitiated CoverageNeutral -> Neutral$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2013Sanford C. BernsteinInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)